The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma

Four years after the onset of COVID-19, children’s vaccination rates are stalling and declining. Armed conflicts and weakening of public health systems are to blame

Nearly three decades after Jonas Salk’s passing, his legacy continues to highlight the need for building a different pharmaceutical industry

An increase in local dengue transmissions reported by EU public health agencies has raised concerns about outbreak risks as climate change makes the region more suitable for Aedes mosquitoes

Negotiations surrounding the Pandemic Treaty continue as the deadline for endorsing the new mechanism approaches. However, the version under discussion fails to address critical issues pertaining to health equity

The Colombian government recently issued a compulsory license for HIV drug dolutegravir, making the treatment more accessible for thousands of people

Health activists and scientists in Europe met to develop strategies to build regional public pharmaceutical infrastructure as pandemic lessons seems lost on governments and producers

Lula’s government is fulfilling his promise to health movements by progressing works on the Health Economic-Industrial Complex, with the aim to provide Brazil’s health system with independence from transnational corporations

A growing number of organizations in Europe is demanding a complete overhaul of regional pharma policies in order to protect people’s health over profits

Pandemic Treaty talks face hurdles as equity concerns, corporate dominance, and calls for fair health frameworks remain unaddressed

A recent deal struck between Johnson & Johnson and the Global Drug Facility promises improved access to bedaquiline in a number of low income countries, but fails to address structural problems

The UK-India FTA could have a drastic impact on the cost of drugs as well as the timely entry of generic medicines in India and other developing countries.